Committee on Energy and Commerce, Democrats Home Page
Who We Are Schedule What's New
View Printable Version
Home Page > Hearing - 110th Congress

HEARING


Assessing the Safety of our Nation's Drug Supply

Subcommittee on Health
Wednesday, May 9, 2007, 10:00 a.m.
2123 Rayburn House Office Building


Hearing Webcast

(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)

Connect to the Archived Video Webcast of this Hearing (100 kbps) or Download

Windows Media Player is required for Committee Webcasts.


Witness List & Prepared Testimony (pdf files)
Panel I
Steven K. Galson, M.D., M.P.H
Director
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
Marcia Crosse, Ph.D.
Director, Health Care Issues
U.S. Government Accountability Office
441 G Street, N.W., Room 5A14
Washington, D.C. 20548
Panel II
Lisa Van Syckel
Flemington, New Jersey
Ellen V. Sigal, Ph.D.
Friends of Cancer Research
2231 Crystal Drive, Suite 200
Arlington, VA 22202
John Powers III, M.D., F.A.C.P, F.I.D.S.A
Olney, Maryland
R. John Theriault
Chief Security Officer & Vice President
Pfizer, Inc.
Global Security
235 East 42nd Street,
32nd Floor, MS 1
New York, NY 10017
Sharon Levine, M.D.
Associate Executive Director
The Permanente Medical Group
1950 Franklin Street
Oakland, CA 94612
Caroline Loew, Ph.D.
Senior Vice President
Science and Regulatory Affairs
PhRMA
950 F Street, NW
Washington, DC 20004
Diane Thompson
Vice President, Public Policy and Communications
Elizabeth Glaser Pediatric AIDS Foundation
1140 Connecticut Avenue, N.W.,
Suite 200
Washington, DC 20036
Susan S. Ellenberg, Ph.D.
Professor of Biostatistics
Associate Dean for Clinical Research
University of Pennsylvania School of Medicine
Center for Clinical Epidemiology and Biostatistics
611 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021



Hearing Transcript

Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site.